BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35604052)

  • 1. Generalized morphea after COVID-19 vaccines: a case series.
    Paolino G; Campochiaro C; Di Nicola MR; Mercuri SR; Rizzo N; Dagna L; Rongioletti F; De Luca G
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e680-e682. PubMed ID: 35604052
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review.
    Antoñanzas J; Rodríguez-Garijo N; Estenaga Á; Morelló-Vicente A; España A; Aguado L
    Dermatol Ther; 2022 Sep; 35(9):e15709. PubMed ID: 35811413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Morphea After COVID-19 Vaccination.
    Sharma A; Sandhu A
    Dermatitis; 2024; 35(2):187-188. PubMed ID: 37610869
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphea and COVID-19 mRNA vaccine.
    Sookaromdee P; Wiwanitkit V
    Int J Dermatol; 2022 May; 61(5):e162. PubMed ID: 35230704
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins.
    Metin Z; Celepli P
    Int J Dermatol; 2022 May; 61(5):639-641. PubMed ID: 35073411
    [No Abstract]   [Full Text] [Related]  

  • 6. Acid-fast bacteria in scleroderma and morphea.
    Cantwell AR; Kelso DW
    Arch Dermatol; 1971 Jul; 104(1):21-5. PubMed ID: 5120159
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphoea following COVID-19 vaccination.
    Oh DAQ; Tee SI; Heng YK
    Clin Exp Dermatol; 2022 Dec; 47(12):2293-2295. PubMed ID: 35906013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.
    Fett N
    Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized scleroderma: clinical spectrum and therapeutic update.
    Careta MF; Romiti R
    An Bras Dermatol; 2015; 90(1):62-73. PubMed ID: 25672301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
    Arif T; Masood Q; Singh J; Hassan I
    BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral multisegmental morphea.
    Fleming KF; Wu JJ; Dyson SW; Tsuchiya AM
    Cutis; 2011 Jul; 88(1):41-2. PubMed ID: 21877506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphea and localized scleroderma in children.
    Vierra E; Cunningham BB
    Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
    Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
    J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphea Sculpted in Silica: A Case Report of Limited Cutaneous Systemic Sclerosis in a Woman with Long-Time Exposure to Silica Dust.
    Pedro Gomes J; Shoenfeld Y
    Isr Med Assoc J; 2017 Jul; 19(7):459-460. PubMed ID: 28786264
    [No Abstract]   [Full Text] [Related]  

  • 15. [The clinical picture of morphea].
    Wojas-Pelc A; Wielowieyska-Szybińska D
    Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RF - Generalized Morphea: Definition and Associations.
    García-Vázquez A; Guillen-Climent S; Ramón Quiles MD
    Actas Dermosifiliogr (Engl Ed); 2021 Apr; 112(4):366-367. PubMed ID: 33227275
    [No Abstract]   [Full Text] [Related]  

  • 17. Amyloid deposition associated with generalized morphea-like scleroderma.
    Sumi K; Yamamoto T; Yokozeki H; Nishioka K
    Eur J Dermatol; 2003; 13(5):509-11. PubMed ID: 14693503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical injury as a provoking factor in three patients with scleroderma.
    Komócsi A; Tóvári E; Kovács J; Czirják L
    Clin Exp Rheumatol; 2000; 18(5):622-4. PubMed ID: 11072607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes in systemic scleroderma and generalized morphea.
    O'Loughlin S; Tappeiner G; Jordon RE
    Dermatologica; 1980; 160(1):25-30. PubMed ID: 7351267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric morphea state-of-the-art literature review: Reframing morphea as a systemic disease.
    Sink JR; Chiu YE
    Pediatr Dermatol; 2021 Sep; 38(5):1020-1031. PubMed ID: 34272748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.